Daiwa Securities Group Inc. Pfizer Inc Transaction History

Daiwa Securities Group Inc.

$21.6 Billion
Q3 2024

A detailed history of Daiwa Securities Group Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 804,522 shares of PFE stock, worth $20.6 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

804,522

Previous 638,911 25.92%

Holding current value

$20.6 Million

Previous $17.9 Million 30.25%

% of portfolio

0.11%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $4.59 Million - $5.2 Million	165,611 Added 25.92%	804,522 $23.3 Million
Q2 2024 Aug 07, 2024	BUY	$25.26 - $29.6 $1.4 Million - $1.64 Million	55,442 Added 9.5%	638,911 $17.9 Million
Q1 2024 May 02, 2024	BUY	$25.89 - $29.73 $1.89 Million - $2.18 Million	73,183 Added 14.34%	583,469 $16.2 Million
Q4 2023 Jan 31, 2024	BUY	$26.13 - $33.94 $626,754 - $814,084	23,986 Added 4.93%	510,286 $14.7 Million
Q3 2023 Nov 01, 2023	BUY	$32.09 - $37.51 $1 Million - $1.17 Million	31,171 Added 6.85%	486,300 $16.1 Million
Q2 2023 Jul 31, 2023	BUY	$36.12 - $41.79 $306,117 - $354,170	8,475 Added 1.9%	455,129 $16.7 Million
Q1 2023 May 02, 2023	BUY	$39.39 - $51.28 $1.06 Million - $1.38 Million	26,964 Added 6.42%	446,654 $18.2 Million
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $1.27 Million - $1.65 Million	30,344 Added 7.79%	419,690 $21.5 Million
Q3 2022 Nov 02, 2022	BUY	$43.76 - $53.42 $576,975 - $704,342	13,185 Added 3.51%	389,346 $17 Million
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $356,140 - $422,271	7,654 Added 2.08%	376,161 $19.7 Million
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $396,744 - $491,615	-8,672 Reduced 2.3%	368,507 $19.1 Million
Q4 2021 Feb 03, 2022	SELL	$41.32 - $61.25 $128,381 - $190,303	-3,107 Reduced 0.82%	377,179 $22.3 Million
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $1.05 Million - $1.34 Million	26,672 Added 7.54%	380,286 $16.4 Million
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $477,638 - $541,084	13,301 Added 3.91%	353,614 $13.8 Million
Q1 2021 May 03, 2021	BUY	$33.49 - $37.77 $145,078 - $163,619	4,332 Added 1.29%	340,313 $12.3 Million
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $213,270 - $271,192	6,372 Added 1.93%	335,981 $12.4 Million
Q3 2020 Nov 02, 2020	SELL	$31.75 - $37.25 $254,285 - $298,335	-8,009 Reduced 2.37%	329,609 $12.1 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $710,672 - $1.02 Million	26,292 Added 8.45%	337,618 $11 Million
Q4 2019 Jan 31, 2020	BUY	$32.92 - $37.36 $114,133 - $129,527	3,467 Added 1.13%	311,326 $12.2 Million
Q3 2019 Nov 04, 2019	BUY	$32.49 - $42.13 $474,094 - $614,760	14,592 Added 4.98%	307,859 $11.1 Million
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $101,066 - $113,474	-2,733 Reduced 0.92%	293,267 $12.7 Million
Q1 2019 Apr 26, 2019	SELL	$37.5 - $41.2 $551,212 - $605,598	-14,699 Reduced 4.73%	296,000 $12.6 Million
Q4 2018 Feb 05, 2019	BUY	$38.47 - $43.86 $437,403 - $498,688	11,370 Added 3.8%	310,699 $13.6 Million
Q3 2018 Nov 01, 2018	BUY	$34.47 - $41.81 $416,397 - $505,064	12,080 Added 4.21%	299,329 $13.2 Million
Q2 2018 Jul 30, 2018	SELL	$32.98 - $35.16 $1.63 Million - $1.74 Million	-49,515 Reduced 14.7%	287,249 $10.4 Million
Q1 2018 May 02, 2018	BUY	$31.91 - $37.02 $366,933 - $425,692	11,499 Added 3.54%	336,764 $12 Million
Q4 2017 Feb 06, 2018	BUY	$33.26 - $35.29 $672,783 - $713,846	20,228 Added 6.63%	325,265 $11.8 Million
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $9.46 Million - $10.4 Million	305,037	305,037 $10.9 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Pfizer Inc Transaction History